World In Vitro Diagnostic Testing Market Examined by TriMark Publications in New Study Available at

Share Article

New cutting-edge report “In Vitro Diagnostic Testing World Markets” worked out by TriMark Publications is now available at

TD The Market Publishers Ltd

Technological advances, cost pressures, changes in reimbursement, expansion of molecular diagnostic technologies (nucleic acid amplification, sequencing, microarrays and in situ hybridisation) and surging interest in the genomic testing are the factors that are driving the in vitro diagnostic (IVD) testing market.

IVD manufacturers are regularly enhancing and developing their product offerings to keep abreast of ever-soaring end-user desires and needs. Whilst top players in the IVD industry try to boost market share by ramping up new product development efforts in point-of-care testing (POCT) – for instance, Alere and Abbott – the industry is still very fragmented, with room available for smaller players to come into and compete with up-to-the-minute platforms and wide-ranging test menus. As the global IVD markets keep on developing – shaped by booming demand for IVD services and products – the industry is also seeing sky-rocketing deal activity in a broad range of sectors. Within these rapidly evolving spheres of the diagnostics marketplace, strategic acquisitions allow firms to complement current portfolios with pertinent products and capabilities.

New cutting-edge report “In Vitro Diagnostic Testing World Markets” worked out by TriMark Publications is now available at

Report Details:

Title: In Vitro Diagnostic Testing World Markets
Published: January, 2015
Pages: 342
Price: US$ 4,500.00

The study is aimed at examining the global IVD testing marketplace, covering POC testing, diabetes and glucose, chemistry, hematology, immunoassay, coagulation, molecular diagnostics, pathology, histology and cytology, microbiology, and blood banking. It examines the popular clinical analytical activities currently in use in the IVD sector for disease diagnosis and management; includes the dominant clinical-measurement instruments and the concurrent supplies and reagents as used in hospitals and large reference and specialty CLIA licensed labs, and also physicians’ offices and POC testing. It assesses the likely benefits of the diagnostics techniques for different sectors of the scientific and medical communities in serving patients and managing disease, and it assesses the market drivers and restraints for IVD tests from the standpoint of these communities. It provides estimates of the IVD market size and gives insights into the market’s future development path, as well as analyses the actual size and expected growth of leading segments. It assesses different business models in diagnostics, and contains valuable strategic recommendations for business opportunities in the immediate future. The report surveys the majority of the biotech companies, in the USA and worldwide, it provides actual and forecast market shares of these players.

Report Scope:

  • Identification of the major IVD market segments.
  • Current estimates and future forecasts of the US and global markets for IVDs for different sectors of diseases.
  • Examination of the key market drivers that have led to the worldwide race for innovative IVDs.
  • Analysis of the influence of existing products and a look at the future of the diagnostics sector.
  • Deep insights into the diagnostics products in development and the companies striving to launch these novel products onto the market in the immediate future.
  • Evaluation of the worldwide activity of IVD with distinguishing contributions from the top 5 country markets including the USA, Europe, China, Japan and ROW.

More new reports by the publisher can be found at TriMark page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Natalia Aster
Follow us on